REN and COVID-19: In the subgroups with enough participants to conduct analyses, those with use of antibacterials, diuretics, betablockers, calcium channel blockers, drugs for obstructive airway disease and renin–angiotensin medication had increased odds of severe COVID-19 (Fig 3) compared to those with no use for the past six months.